Duplicated Citations and a Missing Phase III Result Cloud Review of Nanocarrier Hype in Pancreatic Cancer
A Matters Arising letter identifies duplicated citations, phantom reference numbers, and an omitted phase III trial outcome in a prominent ...
A Matters Arising letter identifies duplicated citations, phantom reference numbers, and an omitted phase III trial outcome in a prominent ...
A Phase III trial of 807 patients found the trastuzumab biosimilar EG12014 statistically equivalent to reference trastuzumab in efficacy, safety, ...
The first year-long randomised trial of tiotropium add-on therapy in children aged one to five with severe preschool asthma found ...
A phase III trial of obinutuzumab β shows striking efficacy in aquaporin-4-IgG-positive neuromyelitis optica spectrum disorder, deepening questions about which ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine